An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.
An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.
复制标题
DOI:
10.1038/nm.3468
复制
发表时间:
2014-04
期刊:
影响因子:
82.9
通讯作者:
Moura IC
中科院分区:
文献类型:
--
作者:
Dussiot M;Maciel TT;Fricot A;Chartier C;Negre O;Veiga J;Grapton D;Paubelle E;Payen E;Beuzard Y;Leboulch P;Ribeil JA;Arlet JB;Coté F;Courtois G;Ginzburg YZ;Daniel TO;Chopra R;Sung V;Hermine O;Moura IC
The pathophysiology of ineffective erythropoiesis in β-thalassemia is poorly understood. We report that RAP-011, an activin receptor IIA (ActRIIA) ligand trap, improved ineffective erythropoiesis, corrected anemia and limited iron overload in a mouse model of β-thalassemia intermedia. Expression of growth differentiation factor 11 (GDF11), an ActRIIA ligand, was increased in splenic erythroblasts from thalassemic mice and in erythroblasts and sera from subjects with β-thalassemia. Inactivation of GDF11 decreased oxidative stress and the amount of α-globin membrane precipitates, resulting in increased terminal erythroid differentiation. Abnormal GDF11 expression was dependent on reactive oxygen species, suggesting the existence of an autocrine amplification loop in β-thalassemia. GDF11 inactivation also corrected the abnormal ratio of immature/mature erythroblasts by inducing apoptosis of immature erythroblasts through the Fas–Fas ligand pathway. Taken together, these observations suggest that ActRIIA ligand traps may have therapeutic relevance in β-thalassemia by suppressing the deleterious effects of GDF11, a cytokine which blocks terminal erythroid maturation through an autocrine amplification loop involving oxidative stress and α-globin precipitation.
登录
查看更多内容
影响因子:
5.9
作者:
NATHAN, DG;GUNN, RB
通讯作者:
GUNN, RB
影响因子:
3.2
作者:
Schrier, SL
通讯作者:
Schrier, SL
影响因子:
3.2
作者:
Paulson RF;Shi L;Wu DC
通讯作者:
Wu DC
影响因子:
7.4
作者:
Rivella, Stefano
通讯作者:
Rivella, Stefano
影响因子:
20.3
作者:
Chadwick, K;Wang, LS;Bhatia, M
通讯作者:
Bhatia, M